Adriamycin vs. Epirubicin

Study Details:

Species: Canines

Tumor: Dogs with Hemangiosarcomas

For more information: Click Here or CONTACT DR. MICHELE STEFFEY (530-752-1393) FOR INCLUSION IN THE STUDY.

Purpose of the Study Comparing Adriamycin vs. Epirubicin over the course of six doses. Inclusion criteria:  Canine patients that have Splenic Hemangiosarcoma and has ruptured with a biopsy to confirm NO liver metastasis.